Clinical Trial Update: Clinical Trial to Evaluate the Efficacy of Bifidobacterium BB-12® in the Treatment of Infantile Colic [NA]

View source ↗

Summary

Clinical trial evaluating the efficacy of Bifidobacterium BB-12® for infantile colic has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Colic

Drugs mentioned

• Bifidobacterium BB-12® (Bifidobacterium BB-12)

Snippet

Sponsor: SOFAR S.p.A. | Conditions: Infantile Colic, Colic, Infantile | NA | Status: COMPLETED | Results posted: 2020-01-23